Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment

Joint Authors

Lv, Longqin
Mao, Shanping
Dong, Huimin
Fang, Congcong
Liu, Baohui

Source

Parkinson’s Disease

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-03-24

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Diseases
Medicine

Abstract EN

Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder mainly in middle-elderly population, which represents diverse nonmotor symptoms (NMS) besides such well-documented motor symptoms as bradykinesia, resting tremor, rigidity, and postural instability.

With the advancement of aging trend worldwide, the global prevalence of PD is mounting up year after year.

Nowadays, accumulating lines of studies have given a comprehensive and thorough coverage of motor symptoms in PD.

Yet much less attention as compared has been paid to the nonmotor symptoms of PD, such as cognition deficits.

Of note, a patient with PD who suffers from cognitive impairment may harbour a statistically significantly higher risk of progressing toward dementia, which negatively affects their life expectancy and daily functioning and overall lowers the global quality of life.

Furthermore, it is a widely held view that cognitive dysfunction does not just occur in the late stage of PD.

On the basis of numerous studies, mild cognitive impairment (MCI) is a harbinger of dementia in PD, which is observed as an intermediate state with considerable variability; some patients remain stable and some even revert to normal cognition.

Considered that the timing, profile, and rate of cognitive impairment vary greatly among PD individuals, it is extremely urgent for researchers and clinicians alike to identify and predict future cognitive decline in this population.

Simultaneously, early screening and canonical management of PD with cognitive deficits are very imperative to postpone the disease progression and improve the prognosis of patients.

In our review, we focus on a description of cognitive decline in PD, expound emphatically the pathological mechanisms underlying cognition deficits in PD, then give a comprehensive overview of specific therapeutic strategies, and finally dissect what fresh insights may bring new exciting prospect for the subfield.

American Psychological Association (APA)

Fang, Congcong& Lv, Longqin& Mao, Shanping& Dong, Huimin& Liu, Baohui. 2020. Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment. Parkinson’s Disease،Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1206400

Modern Language Association (MLA)

Fang, Congcong…[et al.]. Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment. Parkinson’s Disease No. 2020 (2020), pp.1-11.
https://search.emarefa.net/detail/BIM-1206400

American Medical Association (AMA)

Fang, Congcong& Lv, Longqin& Mao, Shanping& Dong, Huimin& Liu, Baohui. Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment. Parkinson’s Disease. 2020. Vol. 2020, no. 2020, pp.1-11.
https://search.emarefa.net/detail/BIM-1206400

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1206400